Companion Diagnostics Market Report: Trends, Insights, and Forecast for 2030

According to the study by Next Move Strategy Consulting, the global Companion Diagnostics Market size is predicted to reach USD 9.02 billion with a CAGR of 14.8% by 2030.

Companion Diagnostic (CDx) is a clinical test co-developed with a therapeutic drug for screening the responders and non-responders to that particular drug. 

According to data provided by World Health Organization in 2018; 1 in 6 deaths are caused due to cancer every year. 

Request for a FREE Sample PDF: https://www.nextmsc.com/companion-diagnostics-market/request-sample